|
Código del ensayo 68284528MMY3004 (CARTITUDE 5) |
|
Ensayo Phase 3 Randomized Study Comparing Bortezomib, Lenalidomide And Dexamethasone (Vrd)Followed By Ciltacabtagene Autoleucel, A Chimeric Antigen Receptor T Cell (Car-T) Therapy Directed Against Bcma Versus Bortezomib, Lenalidomide, And Dexamethasone (Vrd)Followed By Lenalidomide And Dexamethasone (Rd) Therapy In Participants With Newly Diagnosed Multiple Myeloma For Whom Hematopoietic Stem Cell Transplant Is Not Planned As Initial Therapy |
|
Estado Abierto a inclusión |
|
Localización Tumoral Hematológicos |
|
Tipo de tumor Mielomas |
|
Tipo de ensayo Ensayo de Fase III |
|
Tipo de tratamiento |
|
Situación clínica |
|
Centro |
